CIK 0001709941 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
BioAge Labs, Inc.
Sign in to watch- Ticker
- BIOA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474721157
- Phone
- 510-806-1445
- Business address
- 5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA, 94608
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-03 | Pande Vijay Satyanand Director | Purchase | +25,306 | $19.90 | $504K | 1,119,195 |
| 2024-10-02 | Pande Vijay Satyanand Director | Purchase | +67,096 | $19.73 | $1.3M | 1,093,889 |
| 2024-10-01 | Pande Vijay Satyanand Director | Purchase | +126,793 | $19.73 | $2.5M | 1,026,793 |
| 2024-09-27 | Hemrajani Rekha Director | Purchase | +3,000 | $18.00 | $54K | 3,000 |
| 2024-09-27 | Barton Shane Principal Accounting Officer | Purchase | +2,632 | $18.00 | $47K | 2,632 |
| 2024-09-27 | Cormorant Asset Management, LP Former 10% Owner | Purchase | +450,000 | $18.00 | $8.1M | 1,629,529 |
| 2024-09-27 | Pande Vijay Satyanand Director | Purchase | +900,000 | $18.00 | $16.2M | 900,000 |
| 2024-09-27 | ENRIGHT PATRICK G Director | Purchase | +400,000 | $18.00 | $7.2M | 1,710,589 |
| 2024-09-27 | HEALY JAMES Director | Purchase | +588,888 | $18.00 | $10.6M | 2,227,124 |
| 2024-09-27 | HEALY JAMES Director | Purchase | +11,113 | $18.00 | $200K | 11,113 |
| 2024-09-27 | HEALY JAMES Director | Purchase | +18,353 | $18.00 | $330K | 18,353 |
| 2024-09-27 | HEALY JAMES Director | Purchase | +21,814 | $18.00 | $393K | 21,814 |
| 2024-09-27 | HEALY JAMES Director | Purchase | +26,497 | $18.00 | $477K | 26,497 |
Page 1 of 1 · 13 trades